Zenas BioPharma, Inc. GAAP EPS of -$1.22
Source: SeekingAlpha
2025-11-12 09:55:32 ET
More on Zenas BioPharma, Inc.
- Zenas BioPharma: Two Late-Stage Catalysts And A $2B InnoCare Deal
- Zenas BioPharma rises after Wedbush raises price target
- Zenas climbs on licensing deal with InnoCare
- Seeking Alpha’s Quant Rating on Zenas BioPharma, Inc.
- Historical earnings data for Zenas BioPharma, Inc.
Read the full article on Seeking Alpha
For further details see:
Zenas BioPharma, Inc. GAAP EPS of -$1.22
ProShares UltraPro Short NASDAQ Biotechnology
NASDAQ: ZBIO
ZBIO Trading
-3.26% G/L:
$24.06 Last:
166,899 Volume:
$24.93 Open:
ZBIO Latest News
ZBIO Stock Data
$1,157,322,819
29,738,258
0.79%
29
N/A
Biotechnology & Life Sciences
Healthcare
US
Waltham
